These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2726283)

  • 21. Effect of low energy diet and weight loss on major risk factors, central obesity and associated disturbances in patients with essential hypertension.
    Singh RB; Niaz MA; Bishnoi I; Singh U; Begum R; Rastogi SS
    J Hum Hypertens; 1995 May; 9(5):355-62. PubMed ID: 7623373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dietetic-hygienic measures in the control of arterial hypertension in obese females].
    Pecelj-Gec M; Jorga J; Marmut Z; Plećas D; Mirić G
    Srp Arh Celok Lek; 1992; 120(9-10):273-5. PubMed ID: 1306018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure and arm circumference during large weight reduction in normotensive and borderline hypertensive obese patients.
    Andersen T; Stokholm KH; Nielsen PE
    J Clin Hypertens; 1987 Dec; 3(4):547-53. PubMed ID: 3453387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overweight, obesity, and blood pressure: the effects of modest weight reduction.
    Mertens IL; Van Gaal LF
    Obes Res; 2000 May; 8(3):270-8. PubMed ID: 10832771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and management of hypertension in obesity.
    Narkiewicz K
    Obes Rev; 2006 May; 7(2):155-62. PubMed ID: 16629872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term changes in blood pressure in extremely obese patients who have undergone bariatric surgery.
    Fernstrom JD; Courcoulas AP; Houck PR; Fernstrom MH
    Arch Surg; 2006 Mar; 141(3):276-83. PubMed ID: 16549693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Different therapies in the treatment of obesity in hypertensive patients].
    Monego ET; Peixoto Mdo R; Jardim PC; Sousa AL; Braga VL; Moura MF
    Arq Bras Cardiol; 1996 Jun; 66(6):343-7. PubMed ID: 9035450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of sustained hypertension and obesity in urban and rural school going children in Ludhiana.
    Mohan B; Kumar N; Aslam N; Rangbulla A; Kumbkarni S; Sood NK; Wander GS
    Indian Heart J; 2004; 56(4):310-4. PubMed ID: 15586739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
    Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of weight status on the recommendations of and adherence to lifestyle modifications among hypertensive adults.
    Xu KT; Ragain RM
    J Hum Hypertens; 2005 May; 19(5):365-71. PubMed ID: 15729379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Obesity and hypertension].
    Verdecchia P; Trimarco B
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):54S-59S. PubMed ID: 18773751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertension and obesity.
    Dustan HP
    Prim Care; 1991 Sep; 18(3):495-507. PubMed ID: 1946785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The influence of neuroleptanalgesia on blood volume and circulatory pressures (author's transl)].
    Linderkamp O; Dehnert-Hilscher A
    Anaesthesist; 1977 Jul; 26(7):349-53. PubMed ID: 889068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of a low caloric diet on blood pressure and left ventricular hypertrophy in overweight hypertensive patients].
    Skołuda A; Poprawski K
    Kardiol Pol; 1990; 33(9-10):24-8. PubMed ID: 2150082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Practical and clinical aspects of multifactorial therapy in obesity].
    Grüne S; Kahn JM; Edmonds D; Merkt S; Greminger P
    Schweiz Rundsch Med Prax; 1992 Feb; 81(9):239-42. PubMed ID: 1542761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension.
    Berglund A; Andersson OK; Berglund G; Fagerberg B
    BMJ; 1989 Aug; 299(6697):480-5. PubMed ID: 2507028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.